This Notice announces the participation of the National Institute on Drug Abuse (NIDA) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in NOT-NS-08-009, for competitive administrative supplements to generate reagents for production of high-quality low-cost monoclonal antibodies by the NIH-funded NeuroMab Facility.